anaemia Archives -

Astellas’ oral HIF-PH inhibitor Evrenzo has become the first drug in the class to be recommended for routine

NICE backs Astellas’ oral therapy Evrenzo for anaemia in kidney disease

https://pharmaphorum.com/news/nice-backs-astellas-oral-therapy-evrenzo-for-anaemia-in-kidney-disease/

GSK goes for gold as FDA starts review of daprodustat

Phil Taylor Akebia Therapeutics, anaemia, AstraZeneca, chronic kidney disease, daprodustat, FibroGen, GlaxoSmithKline, roxadustat, vadadustat 0 Comment

GlaxoSmithKline says the FDA has started its review of daprodustat for anaemia associated with chronic kidney disease (CKD),

GSK goes for gold as FDA starts review of daprodustat

https://pharmaphorum.com/news/fda-starts-review-of-gsks-kidney-drug-daprodustat/

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

Market Access/ News/ News

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

Phil Taylor Akebia Therapeutics, anaemia, Astellas, chronic kidney disease, daprodustat, EU, FibroGen, GlaxoSmithKline, Haematology, regulatory approval, roxadustat, vadadustat 0 Comment

The EU regulator has approved FibroGen and Astellas Evrenzo for adults with anaemia caused by chronic kidney disease

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

https://pharmaphorum.com/news/after-fda-snub-ema-backs-fibrogen-astellas-roxadustat/

News

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

Richard Staines anaemia, Astellas, AstraZeneca, chronic kidney disease, Duvroq, FibroGen, GlaxoSmithKline, Kyowa Kirin 0 Comment

GlaxoSmithKline’s drug for anaemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas. Marketed

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

https://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/

Market Access/ News/ News

Celgene scores FDA okay for thalassaemia drug Reblozyl

Phil Taylor Acceleron, anaemia, beta thalassaemia, Celgene, FDA approval 0 Comment

The FDA has approved Celgene and Acceleron’s Reblozyl, which is the first drug to be approved in the

Celgene scores FDA okay for thalassaemia drug Reblozyl

https://pharmaphorum.com/news/celgene-scores-fda-okay-for-thalassaemia-drug-reblozyl/

GlaxoSmithKline/ News/ UK & Europe

GSK begins phase 3 trials of kidney drug

Richard Staines anaemia, chronic kidney disease, GlaxoSmithKline, nephrology 0 Comment

Daprodustat is potential treatment for anaemia with CKD.

GSK begins phase 3 trials of kidney drug

https://pharmaphorum.com/news/gsk-begins-phase-3-trials-kidney-drug/

Trending

anaemia

Login